Dupilumab Decreases Local Galectin‐10 Expression in Eosinophilic Chronic Rhinosinusitis
Isao Suzaki received grants and honoraria for lectures from Sanofi and honoraria for lectures from GlaxoSmithKline. Shigeharu Ueki received grants and honoraria for lectures from AstraZeneca, honoraria for lectures from GlaxoSmithKline and Sanofi, and grants from VIB, Cytrill, and Maruho Co. Kojiro Hirano received honoraria for lectures from Sanofi. The remaining authors declare no conflicts of interest. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Tomomi Mizuyoshi
- Mio Takeuchi (ORCID: https://orcid.org/0000-0003-2183-7371)
- Kojiro Hirano (ORCID: https://orcid.org/0000-0002-4466-7953)
- Yoshio Ōtani (ORCID: https://orcid.org/0000-0002-5751-6898)
- Keisuke Ito (ORCID: https://orcid.org/0000-0002-8719-9635)
- Tatsuya Kitajima
- Taisuke Hamasaki
- Toshikazu Shimane (ORCID: https://orcid.org/0000-0002-0816-0223)
- Shigeharu Ueki (ORCID: https://orcid.org/0000-0002-3537-7735)
- Mineyo Fukuchi (ORCID: https://orcid.org/0000-0002-1161-9074)
- Isao Suzaki (ORCID: https://orcid.org/0000-0002-9078-1001)
Institutions
- SHOWA Medical University (JP)
- Akita University (JP)
Publication Details
- Journal
- International Forum of Allergy & Rhinology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1002/alr.23614
- Primary Topic
- Eosinophilic Esophagitis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Ministry of Health, Labour and Welfare